Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$819M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$550M |
| 3 |
Boston Scientific
BSX
|
+$303M |
| 4 |
ExxonMobil
XOM
|
+$291M |
| 5 |
Advanced Micro Devices
AMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$513M |
| 2 |
Apple
AAPL
|
+$396M |
| 3 |
Target
TGT
|
+$379M |
| 4 |
Eli Lilly
LLY
|
+$351M |
| 5 |
EOG Resources
EOG
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.82% |
| 2 | Healthcare | 12.74% |
| 3 | Financials | 11.16% |
| 4 | Industrials | 8.55% |
| 5 | Consumer Discretionary | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mastercard
MA
$510B
| $1.71B | 0.6% |
5,458,384
-432,799
| -7% | -$149M |
|
27
Coca-Cola
KO
$381B
| $1.68B | 0.59% |
26,774,504
+2,163,108
| +9% | +$137M |
|
28
Abbott
ABT
$183B
| $1.63B | 0.57% |
15,057,602
+218,904
| +1% | +$24.9M |
|
29
Merck
MRK
$321B
| $1.62B | 0.56% |
17,769,592
+1,092,307
| +7% | +$96.8M |
|
|
30
Wells Fargo
WFC
$258B
| $1.54B | 0.54% |
39,334,349
+18,653,243
| +90% | +$819M |
|
31
RTX Corp
RTX
$289B
| $1.48B | 0.52% |
15,444,113
+352,757
| +2% | +$33.9M |
|
32
CVS Health
CVS
$134B
| $1.45B | 0.5% |
15,685,087
+1,262,093
| +9% | +$123M |
|
33
Elevance Health
ELV
$81.6B
| $1.43B | 0.5% |
2,962,721
+38,645
| +1% | +$19.1M |
|
34
Verizon
VZ
$193B
| $1.4B | 0.49% |
27,656,591
+1,552,239
| +6% | +$78.5M |
|
|
MRSH
35
Marsh
MRSH
$91.4B
| $1.39B | 0.49% |
8,966,150
+501,345
| +6% | +$80.3M |
|
36
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
| $1.33B | 0.46% |
12,101,151
+2,328,235
| +24% | +$263M |
|
37
Qualcomm
QCOM
$160B
| $1.32B | 0.46% |
10,374,962
-2,127,170
| -17% | -$289M |
|
38
NVIDIA
NVDA
$4.72T
| $1.31B | 0.46% |
86,833,360
-14,480,100
| -14% | -$273M |
|
39
Morgan Stanley
MS
$330B
| $1.29B | 0.45% |
16,996,283
-1,302,322
| -7% | -$107M |
|
40
Vertex Pharmaceuticals
VRTX
$122B
| $1.29B | 0.45% |
4,562,949
-384,414
| -8% | -$103M |
|
41
Analog Devices
ADI
$179B
| $1.28B | 0.45% |
8,755,937
-18,731
| -0.2% | -$2.95M |
|
42
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $1.27B | 0.44% |
3,356,768
-202,654
| -6% | -$83M |
|
43
Meta Platforms (Facebook)
META
$1.37T
| $1.26B | 0.44% |
7,807,733
-1,112,772
| -12% | -$215M |
|
44
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
| $1.25B | 0.44% |
15,607,846
+2,504,677
| +19% | +$204M |
|
45
Philip Morris
PM
$299B
| $1.24B | 0.43% |
12,708,366
-394,463
| -3% | -$40.2M |
|
46
Texas Instruments
TXN
$255B
| $1.23B | 0.43% |
8,059,004
-661,860
| -8% | -$111M |
|
47
McDonald's
MCD
$191B
| $1.22B | 0.43% |
4,992,963
+780,876
| +19% | +$192M |
|
|
48
EOG Resources
EOG
$77.5B
| $1.21B | 0.42% |
10,925,499
-2,824,525
| -21% | -$351M |
|
49
Intuit
INTU
$86.3B
| $1.18B | 0.41% |
3,071,570
+259,141
| +9% | +$107M |
|
50
American Electric Power
AEP
$69.5B
| $1.16B | 0.41% |
12,138,145
+2,310,631
| +24% | +$229M |
|
Similar funds
Ameriprise's Q2 2022 Portfolio in Review
As of Q2 2022, Ameriprise held 4,071 positions worth $287B, down 15% from $339B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q2 2022 filing shows 137 new, 1,635 increased, 1,970 reduced and 191 closed positions. Its largest new stake was Aspen Technology Inc: 409,068 shares worth $75.1M. The largest sale was Medtronic, an estimated $513M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q2 2022 buy was Aspen Technology Inc: 409,068 shares worth $75.1M.
- Ameriprise added most to Wells Fargo in Q2 2022, an estimated $819M increase.
- Ameriprise's biggest Q2 2022 reduction was Medtronic, cutting an estimated $513M.
- Ameriprise fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $250M.
- Ameriprise's ten largest holdings make up 14% of its $287B portfolio in Q2 2022.
- Ameriprise opened 137 new positions and closed 191 in Q2 2022.
- Ameriprise's portfolio value fell 15% quarter-over-quarter to $287B.
Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.